Consumers Bancorp reports Q1 FY2027 net income $3.04M, NII up to $10.78M, loans +$30.8M

Consumers Bancorp reported Q1 FY2027 net income of $3.04M, up 15.3% YoY, with net interest income at $10.78M and loans growing by $30.8M. Earnings per share were $0.96. The bank expanded its branch network and saw strong asset quality.

Original reporting
Published Oct 21, 2026, 3:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 3:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Consumers Bancorp reports Q1 FY2027 net income $3.04M, NII up to $10.78M, loans +$30.8M — source image
Decision brief

The 30-second read

$CBKMNeutralMed
01

Why it matters

The earnings release provides the first quantitative update for FY2027, highlighting incremental growth in loans and deposits.

02

Market read

Micro‑cap earnings with modest beat; limited but actionable for short‑term traders monitoring regional bank space.

03

What to watch

Potential future loan pipeline in new branches and modest credit quality improvements could support longer‑term upside.

Relevance 6/10Novelty 6/10Timing: after‑hours release

Background

Consumers Bancorp is a community bank focused on the Ohio market, recently expanding branches in Massillon and Canton.

Company-level read

Ticker impact

$CBKMNeutralMedium confidence
Context

Consumers Bancorp filed an 8‑K reporting Q1 FY2027 net income of $3.04 M, NII $10.78 M and loan growth of $30.8 M – the first public disclosure of these results.

Expected impact

likely slight upward pressure as the market prices in the earnings beat and loan expansion

Evidence & confidence

Small‑cap earnings with modest beat typically generate modest price moves; no guidance or major surprise disclosed.

Market effects

Shows continued loan growth in regional banking sector, but impact limited to niche community banks.

Minor effect on U.S. regional bank sentiment.

Low

Counterpoint

Investors may view the modest earnings as a sign of limited growth potential and could short on expectations of stagnation.

Key entities

  • Consumers Bancorp

    U.S. regional bank (ticker CBKM) reporting Q1 FY2027 results.

Related articles

$CBKMMed

CONSUMERS BANCORP INC /OH/ (CBKM): Results of Operations and Financial Condition

CONSUMERS BANCORP INC /OH/ (CBKM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Consumers Bancorp, Inc. Reports: ● Net income increased by $404 thousand, or 15.3%, to $3.0 million for the three-month period ended September 30, 2026 compared with the same period last year. ● Net interest income increased by $1.2 million, or 12.9%, for the three-m

$CBKMMed

CONSUMERS BANCORP INC /OH/ (CBKM): Results of Operations and Financial Condition

CONSUMERS BANCORP INC /OH/ (CBKM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Consumers Bancorp, Inc. Reports: ● Net income increased by $665 thousand, or 29.0%, for the three-month period and by $2.5 million, or 28.8%, for twelve-month period ended June 30, 2026, compared with the same periods last year. ● Net interest income increased by $1.

$MRCYMed

Mercury Systems 3Q 2026: Revenue $253.15M, EPS $0.21 — 10-Q Summary

Mercury Systems reported 3Q 2026 revenue of $253.15M, up 12.4% YoY, and net income of $13.09M, reversing a prior-year loss. Growth in radar and electronic warfare applications drove results, while C4I revenue declined. Gross margin improved to 35.2% from 27.9%. The company expects to recognize 46% of its $1.193B remaining performance obligations as revenue in the next 12 months.

$SNWVMed

Sanuwave Announces Q3 FY2026 Financial Results

SANUWAVE Health, Inc. (SNWV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sanuwave Announces Q3 FY2026 Financial Results Q3 2026 revenues were $8.6 million, down 24% from $11.3 million in Q3 2025. Q3 2026 gross margin was 77.3%, versus 77.6% in Q3 2025. GAAP operating loss was $1.1 million for Q3 2026 versus operating income of $0.9 millio

$CPIXHighAI 8/10

CUMBERLAND PHARMACEUTICALS REPORTS Q3 2026 FINANCIAL RESULTS & COMPANY UPDATE

CUMBERLAND PHARMACEUTICALS INC (CPIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. CUMBERLAND PHARMACEUTICALS REPORTS Q3 2026 FINANCIAL RESULTS & COMPANY UPDATE $100 million Strategic Transaction Closed Plans to Submit New Drug Application for Ifetroban in DMD Top-Line Results Announced for Systemic Sclerosis Trial NASHVILLE, Tenn. (Nov. 10, 2026) – Cumberland

$ATROHighAI 8/10

Astronics shares tumble on soft fourth quarter revenue outlook

Astronics (ATRO) reported Q3 earnings of $1.08 per share, beating estimates, with revenue up 28.5% YoY to $271.7M. However, shares fell 11% on Q4 revenue guidance of $255M-$275M, below expectations. The company maintained its full-year 2026 revenue guidance. Aerospace segment sales hit a record $245.5M, with strong demand in inflight entertainment and connectivity.